Genomica Completes $13.6M Private Financing

BOULDER, Colo.--Genomica, which describes itself as a pharmacogenomics software company, completed a $13.6 million private placement of series B convertible preferred stock this month. Punk Ziegel managed the placement. Investors included the Kaufman Fund, Anvers L.P., Falcon Technology Partners, Invesco Global Health Sciences Fund, Arch Venture Partners, and Boulder Ventures. Skip Klein, a healthcare analyst with Kaufman, said of Genomica's Discovery Manager software, "Users I've spoken to praise the product for its industrial- strength quality and ease of use. It appears that Genomica has the chance to be the Bloomberg or the Microsoft of genomics." Genomica was established in 1996 by Thomas Marr to commercialize tools he and his team developed at Cold Spring Harbor Laboratory in New York.